This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Talk:Amisulpride: Difference between revisions
>Blackhole added pharmacology |
>Blackhole added 5-HT-2A |
||
| Line 11: | Line 11: | ||
==Pharmacology== | ==Pharmacology== | ||
Amisulpride primarily works by antagonising D<sub>2</sub> and D<sub>3</sub> [[dopamine]] receptors aswell as the 5-HT<sub>7</sub> and 5-HT<sub>2B</sub> [[serotonin]] receptors. | Amisulpride primarily works by antagonising D<sub>2</sub> and D<sub>3</sub> [[dopamine]] receptors aswell as the 5-HT<sub>7</sub>, 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> [[serotonin]] receptors. | ||
It is also known to act as a [[GHB receptor]] agonist and Mu- Delta- Kappa-[[opioid]] agonist<ref>Rehni AK, Singh TG, Chand P: Amisulpride-induced seizurogenic effect: a potential role of opioid receptor-linked transduction systems. Basic Clin Pharmacol Toxicol. 2011 May;108(5):310-7. doi: 10.1111/j.1742-7843.2010.00655.x. Epub 2010 Dec 22. (PubMed ID 21176108)</ref> | It is also known to act as a [[GHB receptor]] agonist and Mu- Delta- Kappa-[[opioid]] agonist<ref>Rehni AK, Singh TG, Chand P: Amisulpride-induced seizurogenic effect: a potential role of opioid receptor-linked transduction systems. Basic Clin Pharmacol Toxicol. 2011 May;108(5):310-7. doi: 10.1111/j.1742-7843.2010.00655.x. Epub 2010 Dec 22. (PubMed ID 21176108)</ref> | ||